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2Abstract
Background	The	study	of	bacterial	symbioses	has	grown	exponentially	in	the	recent	past.	However,
existing	bioinformatic	workflows	of	microbiome	data	analysis	do	commonly	not	integrate	multiple
meta-omics	levels	and	are	mainly	geared	towards	human	microbiomes.	Microbiota	are	better
understood	when	analyzed	in	their	biological	context,	which	is	together	with	their	host	or
environment,	but	this	is	a	limitation	when	studying	non-model	organisms	mainly	due	to	the	lack	of
well-annotated	sequence	references.
Results	Here,	we	present	gNOMO,	a	bioinformatic	pipeline	that	is	specifically	designed	to	process	and
analyze	non-model	organism	samples	of	up	to	three	meta-omics	levels:	metagenomics,
metatranscriptomics,	and	metaproteomics	in	an	integrative	manner.	The	pipeline	has	been	developed
using	the	Snakemake	framework	in	order	to	obtain	an	automated	and	reproducible	workflow.	One	of
the	key	features	is	the	on-the-fly	creation	of	a	tailored	proteogenomic	database	based	on
metagenomics	and	metatranscriptomics	data,	leading	to	improved	protein	identification,	taxonomic
and	functional	analysis.	gNOMO	combines	meta-omics	analysis	of	the	host	with	its	bacterial
population	and	allows	to	investigate	both	host	and	microbiome	of	non-model	organisms	with
commonly	insufficiently	complete	reference	databases.	
Conclusions	Using	experimental	datasets	of	the	German	cockroach	Blattella	germanica	,	a	non-model
organism	with	very	complex	gut	microbiome,	we	show	the	capabilities	of	gNOMO	with	regard	to	meta-
omics	data	integration,	expression	ratio	comparison,	taxonomic	and	functional	analysis	as	well	as
intuitive	output	visualization.	gNOMO	includes	functional	information	of	metagenomics,
metatranscriptomics,	and	metaproteomics	data	of	the	microbiome	in	the	same	visualization
facilitating	the	interpretation	of	the	results.	Moreover,	host	data	can	be	analyzed	in	parallel	to	obtain
an	equivalent	output	that	allows	to	study	the	metabolic	situation	of	the	whole	symbiotic	system.
Finally,	the	metaproteomics	identification	and	annotation	are	optimized	using	a	tailored
proteogenomics	database	automatically	obtained	within	the	gNOMO	workflow.	In	conclusion,	gNOMO
is	a	fully	automated	pipeline,	for	integrating	and	analyzing	multiple	meta-omics	data	and	for
producing	useful	output	visualizations.	In	addition,	it	is	specifically	designed	for	data	from	non-model
3organisms.	The	gNOMO	pipeline	is	freely	available	under	the	Apache	2.0	open-source	license	and	can
be	downloaded	from	https://gitlab.com/rki_bioinformatics/gnomo	.
Background
Symbiosis	is	a	widespread	relationship	present	in	all	groups	of	organisms	but	intensely	developed
between	animals	and	bacteria	that	benefit	from	each	other	in	order	to	survive.	Consequently,	both
acquire	an	evolutionary	advantage	in	comparison	to	individuals	lacking	this	relationship.	Two	different
types	of	symbiosis	can	be	distinguished:	ectosymbiosis,	in	which	bacteria	are	attached	to	the	surface
of	the	host,	and	endosymbiosis,	which	usually	is	a	mutualistic	relationship,	where	bacteria	live
intracellularly	in	the	host	and	are	transmitted	vertically	[1,2].	To	understand	these	evolutionary
relationships	host	and	symbionts	are	best	studied	together.	In	mutualistic	symbiosis,	the	eukaryotes
provide	a	safe	environment	for	endosymbiotic	bacteria	that	live	in	close	interaction	with	the	host.	In
return,	the	endosymbionts	provide	nutrients	and	metabolites	(such	as	essential	amino	acids	or
vitamins)	to	the	host	that	cannot	be	obtained	in	any	other	way.	For	example,	it	has	been	estimated
that	around	15%	of	insect	species	maintain	endosymbiotic	associations	with	bacteria	that	supply	the
host	with	the	nutrients	that	are	lacking	in	their	diets	[3].	On	the	other	hand,	most	insects	possess	a
gut	microbiome	that	affects	the	physiology	of	the	host	by,	for	example,	contributing	to	metabolic	and
nutritional	needs,	and	the	immune	system	development	[4].	Recently,	many	studies	have	been
performed	in	humans	to	study	the	gut	microbiota	[5],	but	non-model	organisms	require	further
investigations	to	better	understand	this	specific	type	of	symbiosis.	In	this	context,	cockroaches	are	a
suitable	model,	because	they	have	two	symbiotic	systems,	i.e.	an	endosymbiont	(Blattabacterium
cuenoti)	in	the	fat	body	and	a	rich	and	complex	gut	microbiota	[6,7].	Blattella	germanica	is	a
hemimetabolous	insect	(it	has	an	incomplete	metamorphosis)	with	three	developmental	stages.
Regarding	its	symbionts,	genome	analysis	demonstrated	that	the	endosymbiont	Blattabacterium
contributes	to	the	nitrogen	(N)	recycling	and	the	synthesis	of	essential	amino	acids	[8],	but	the
function	of	the	gut	microbiota	in	cockroaches	still	has	to	be	elucidated.	It	has	been	shown	that	the	gut
microbiome	of	cockroaches	shows	much	overlap	with	the	one	in	humans	probably	reflecting	a	similar
omnivorous	diet	[6,9,10].	
4Recently,	research	interests	in	microbial	communities	have	been	strongly	increased	due	to	findings
on	the	impact	of	the	microbiome	on	human	health	[11,12].	Microbiome	studies	often	employ	meta-
omics	techniques	such	as	metagenomics	[13]	that	aims	to	analyze	the	genetic	material	from	all
members	in	a	microbial	community	sample.	Despite	many	advantages,	metagenomics	still	presents	a
static	gene-centric	approach	that	cannot	assess	temporal	dynamics	and	functional	activities	of
complex	microbial	populations	[14].	To	gain	insights	into	the	dynamic	functional	repertoire	of
microbial	communities,	further	techniques	such	as	metatranscriptomics	and	metaproteomics	have
been	established	in	recent	years	[15,	16].	Beyond	the	genome	level,	these	meta-omics	analysis
approaches	allow	studying	complex	microbial	systems	and	their	host	interactions	at	the	gene
expression	level	(transcripts	and	proteins,	respectively).	Used	separately,	metagenomics,
metatranscriptomics,	and	metaproteomics	are	already	powerful	because	they	complement	and
mutually	support	each	other.	In	the	past,	powerful	tailored	bioinformatic	solutions	have	been
developed	for	the	individual	meta-omics	analysis	levels	[13,15,16].	However,	the	true	strength
unfolds	when	these	analysis	techniques	are	integrated	[17,18].	As	a	holistic	approach,	a	complete
meta-omics	integration	can	extend	the	capabilities	of	microbiome	and	host-related	studies	in	various
ways.	Most	importantly,	integrating	multiple	meta-omics	levels	allows	to	expand	the	possibilities	of
biological	interpretation	and	to	investigate	biological	pathways	from	a	more	comprehensive
perspective.	Compared	to	single-omics	strategies,	an	integrative	approach	provides	a	deeper	and
more	thorough	understanding	of	how	the	key	players	of	microbial	communities	regulate	underlying
pathway	mechanisms	[19].
While	the	integration	of	meta-omics	has	been	described	in	previous	studies	[20],	its	potential	has	not
been	fully	exploited	so	far.	In	particular,	the	data	analysis	is	challenging,	because	studies	often
present	customized	in-house	workflows	that	cannot	be	fully	automated	or	are	not	reproducible.	In
general,	automated	multi-omics	analysis	pipelines	are	rare	and	limited	to	few	meta-omics	levels	[21]
and	are	not	tailored	for	host	and	microbiome	analyses	of	non-model	organisms.	
Here,	we	present	gNOMO,	a	meta-omics	software	pipeline	that	allows	integrating	three	different
levels	of	omics	analyses,	derived	from	metagenomics,	metatranscriptomics,	and	metaproteomics
5experiments.	It	provides	two	different,	optionally	iterative	operating	modes:	(i)	each	of	the	three
omics	levels	can	be	analyzed	separately	and	independently	of	each	other	and	subsequently,	(ii)	up	to
three	omics	layers	can	be	analyzed	in	a	fully	integrated	fashion.	The	workflow	of	gNOMO	starts	from
raw	data	to	essential	processing	steps	and	finally	provides	output	visualizations	for	taxonomic
classification,	functional	metabolic	pathway	profiling,	and	differential	sample	analysis.	The	integration
of	metagenomics,	metatranscriptomics	and	metaproteomics	data	is	possible	due	to	the	production	of
a	tailored	proteogenomic	database,	which	optimizes	the	identification	and	quantification	of	peptides
in	metaproteomics	data	[22,23].	As	microbiota	needs	to	be	analyzed	in	its	context,	the	host	is	also
studied	together	with	the	microbiome.	Host	data	can	be	analyzed	without	a	reference	database,
which	allows	to	study	non-model	organisms,	and	proteins	of	the	host	are	also	identified	with	a	tailored
host	database	obtained	from	genomics	and	transcriptomic	sequences.	The	pipeline	has	been
implemented	using	the	Python-based	Snakemake	[24]	framework	to	perform	fully	automated	and
reproducible	multi-omics	analyses	of	host	and	microbiome	samples.	So	far,	gNOMO	has	been
developed	and	optimized	for	data	from	non-model	organism	samples,	but	it	is	fully	executable	on
generic	sample	types,	for	example,	from	human	or	mouse	microbiomes.	With	gNOMO,	we	aim	to	fill
the	gap	of	barely	existing	multi-omics	pipelines	for	microbial	community	samples	being	able	to
compare	and	integrate	data	at	the	genome,	transcriptome,	and	proteome	level.	
Implementation
gNOMO	is	a	pipeline	that	integrates	multiple	bioinformatic	methods	and	software	tools	to	analyze
metagenomics,	metatranscriptomics	and	metaproteomics	data	and	to	provide	the	results	with	an
easily	readable	final	output.	One	of	the	main	purposes	of	integrating	such	different	kinds	of	multi-
omics	data	is	to	directly	improve	the	analysis	of	microbial	populations	and	to	investigate	their
function	in	poorly	characterized	environments,	such	as	non-model	organisms.	At	the	genome	and
transcriptome	level,	our	pipeline	includes	both	quality	control	and	data	preparation	steps,	of	which
parameters	can	be	adjusted	depending	on	the	quality	of	the	input	data.	In	addition,	gNOMO	allows	to
directly	create	a	proteogenomic	database	from	metagenomics	and	metatranscriptomics	data.	This
important	processing	step	makes	it	possible	to	connect	the	metagenomics	and	metatranscriptomics
6analysis	to	the	protein	identification	at	the	metaproteomics	level.	In	particular,	the	proteogenomic
database	generation	step	leads	to	the	full	integration	of	all	three	omics	levels.		
The	complete	gNOMO	pipeline	is	built	in	Snakemake	[24],	a	management	system	for	bioinformatic
workflows,	that	allows	obtaining	standardized	and	reproducible	output	data.	By	using	Snakemake,	the
input	data	can	be	easily	defined,	and	the	parameters	are	configured	for	their	analysis	by	editing	a
configuration	file.	Further,	the	gNOMO	pipeline	including	all	dependencies	is	available	at	the	BioConda
channel	[25].	Tools	added	to	BioConda	provide	a	user-friendly	installation	because	the	required	tools
and	libraries	are	easily	incorporated	and	automatically	installed	with	the	use	of	Snakemake
environments.	The	gNOMO	pipeline	typically	consists	of	five	main	steps	(Figure	1)::	(1)	pre-
processing,	(2)	metagenomics	and	metatranscriptomics	data	analysis,	(3)	proteogenomic	database
creation,	(4)	metaproteomics	data	analysis,	and	(5)	data	integration.	In	the	following	paragraphs,
these	individual	steps	are	described	in	more	detail.	
Figure	1:	Workflow	overview	of	the	gNOMO	pipeline.	A)	Initial	input	of	metagenomic	(metagenomics)
and	metatranscriptomic	(metatranscriptomics)	sequences.	B)	Pre-processing:	cleaning	and	quality
control	of	metagenomics	and	metatranscriptomics	input	sequences.	C)	metagenomics	and
metatranscriptomics	data	analyses:	consists	of	taxonomic	and	functional	annotations.	D)
Proteogenomic	database	creation	based	on	metagenomics	and	metatranscriptomics	protein
predictions.	E)	Auxiliary	input	of	metaproteomic	(metaproteomics)	tandem	mass	spectrum	data.	F)
metaproteomics	analysis:	also	includes	taxonomic	and	functional	annotations.	G)	Graphical
representation/visualization	of	all	integrated	meta-omics	data.
Pre-processing
The	first	step	includes	various	pre-processing	mechanisms	improving	metagenomics	and
metatranscriptomics	read	quality,	including:	(i)	FastQC	[26]	for	reviewing	the	quality	of	the	reads,	(ii)
PrinSeq	[27]	for	cleaning	and	for	trimming	the	sequences,	(iii)	a	second	quality	control	with	FastQC
and	Fastq-join	[28]	for	binning	the	pair-end	reads.	This	binning	step	is	included	because	our	workflow
is	designed	for	paired-end	reads.
Metagenomic	and	metatranscriptomic	analysis
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tools	include	(i)	a	genome	mapping	against	the	NCBI	non-redundant	(nr)	database	(accessed	5	July
2019)	using	Kaiju	[29],	(ii)	a	protein	prediction	using	both	Prodigal	[30]	for	bacterial	proteins	and	(iii)
Augustus	[31]	for	host	proteins	and	functional	annotation	of	this	predicted	proteins	using	EggNOG
(version	1.0	accessed	5	June	2019)	[32]	to	obtain	KEGG	Orthology	(KO)	identifiers.	The	protein
prediction	follows	an	assembly	of	the	binned	reads	to	ensure	a	proper	functional	annotation.	An
optional	step	is	included	that	requires	the	installation	of	InterProScan	[33].	This	software	is	not
implemented	in	BioConda	but	will	be	automatically	installed	locally	with	the	snakemake	script	and
allows	a	TIGRFAM	[34]	functional	annotation.	Details	regarding	the	quality	of	the	annotation	in
metagenomics	and	metatranscriptomics	are	available	in	the	Additional	file	1	(Additional	file	1:	Table
S1)..	
Proteogenomic	database	generation
The	output	of	the	previous	bacterial	prediction	from	the	metagenomics	and	metatranscriptomics	data
is	used	to	create	a	proteogenomics	database.	This	database	includes	bacterial	and	host	proteins	from
metagenomics,	metatranscriptomics	or	both	kinds	of	data.	A	database	with	both	kinds	of	information
provides	a	comprehensive	reference	for	peptide	and	protein	identification	(see	next	paragraph).	The
proteogenomic	database	obtained	from	the	validation	data	has	been	built	with	the	sequences
resulting	from	the	bacterial	protein	prediction	performed	with	Prodigal.	This	database	(data	of
creation:	19	November	2019)	contains	1	014	200	sequences,	of	which	850	455	are	unique	(i.e.,	occur
only	once	in	the	database).	
Metaproteomic	data	analysis
For	peptide	and	protein	identification,	MS-GF+	[35]	is	used	as	database	search	engine,	employing	the
custom	proteogenomic	database	as	reference	for	peptide-to-spectrum	matching.	Both	taxonomic	and
functional	annotations	of	the	peptides	are	performed	with	Unipept	version	4.0	[36].	The	output
obtained	from	this	step	is	a	taxonomic	annotation	at	three	different	levels	and	the	Enzyme
Commission	(EC)	number	associated	with	each	peptide.	To	assess	the	performance	of	our	tailored
database,	we	compared	the	peptide	identification	yield	with	a	very	complete	human	gut	microbial
8protein	database:	NIH	Human	Microbiome	Project	Gastrointestinal	database	(accessed	25	November
2019)	(Additional	file	1:	Table	S2)..	With	our	tailored	database	we	obtained	four	times	more	peptides
identified	than	using	the	NIH	Gastrointestinal	database.	These	results	are	consistent	with	previous
studies	on	the	use	of	metagenomic	sequences	for	constructing	proteogenomics	databases	[37].	
Meta-omics	data	integration	and	visualization
The	final	step	concerns	the	integration	and	visualization	of	all	three-level	meta-omics	data	and
results.	The	taxonomic	annotation	of	the	microbiome	is	visualized	with	KronaPlots	[38].	These	plots
show	the	taxonomic	distribution	in	each	sample	for	each	data	type.	To	analyze	this	information
further,	Linear	discriminant	analysis	(LDA)	Effect	Size	(LEfSe)	[39]	is	used	that	performs	a	statistical
analysis	on	the	microbiome	data.	LEfSe	identifies	features	most	likely	to	explain	differences	between
conditions	by	coupling	standard	statistical	tests	with	additional	tests	encoding	biological	consistency
and	effect	relevance.	The	statistics	performed	are	Kruskal-Wallis	rank-sum	test	on	classes,	Wilcoxon
rank-sum	test	among	subclasses	and	LDA	score	on	relevant	features.	Taking	account	of	the	effect	size
is	essential	to	properly	analyze	microbiomes.	The	outcome	of	the	statistical	analysis	is	depicted	in	a
graph	with	up	to	two	levels	of	classification,	and	only	the	features	with	a	LDA	score	over	2	are	shown.
This	allows	visualizing	different	conditions	and	different	data	within	the	same	graph.	Finally,	for	the
functional	annotation,	the	representation	of	the	metabolic	pathways	is	included	using	Pathview	[40].
The	Pathview	plots	represent	the	log2	ratio	of	the	means	of	the	different	conditions	and	data
compared,	after	a	fold	change	normalisation.	This	R-based	tool	shows	the	differential	expression	of
the	enzymes	on	graphs	visualizing	the	selected	metabolic	pathways.	Pathview	itself	uses	functional
pathway	information	from	the	Kyoto	Encyclopedia	of	Genes	and	Genomes	(KEGG)	database	[41].
Validation	data
B.	germanica	population	originated	from	a	stable	laboratory	population	housed	by	Dr.	X.	Bellés’	group
at	the	Institute	of	Evolutionary	Biology	(CSIC-UPF,	Barcelona).	It	was	reared	in	chambers	at	the
Institute	for	Integrative	Systems	Biology	(University	of	Valencia)	at	25	°C,	60%	humidity	and	a
photoperiod	of	12L:12D.	Cockroaches	were	fed	dog-food	pellets	(Teklad	global	21%	protein	dog	diet
2021C,	Envigo,	Madison,	USA)	and	water	ad	libitum.	Samples	were	taken	at	10	days	and	20	days	after
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females	were	performed	to	obtain	the	hindgut	of	each	individual.	DNA	and	RNA	samples	were
obtained	from	the	same	hindgut,	with	a	total	of	12	samples	(6	replicates	per	condition).	Protein
samples	were	obtained	from	individuals	of	the	same	age	and	population,	with	a	total	of	8	samples
(with	4	replicates	per	condition).	Hindgut	was	ground	with	a	sterile	plastic	pestle.	DNA	and	RNA
extraction	of	each	hindgut	was	performed	using	Nucleospin	RNA	XS	and	Nucleospin	DNA/RNA	Buffer
Set	(Macherey-Nagel,	France).	Protein	extraction	of	each	hindgut	was	performed	solubilizing	the
ground	hindgut	with	lysis	buffer	(7	M	urea,	2	M	thiourea,	4%	(w/v)	CHAPS).	Metagenomic	sequencing
using	the	Illumina	MiSeq	(2	x	300	bp)	technology	was	done	at	the	FISABIO	(Valencia,	Spain).
Metaproteomics	shotgun	sequencing	was	performed	by	the	Proteomics	Unit	of	the	Servei	Central	de
Suport	a	la	Investigació	Experimental	(SCSIE)	at	the	University	of	Valencia.	
Results
To	illustrate	the	outputs	and	analysis	that	can	be	obtained	from	this	pipeline,	we	used	a	complex	gut
microbiota	dataset	from	the	non-model	organism	B.	germanica,	which	genome	has	been	sequenced
(without	being	fully	annotated)	[42].	This	dataset	consists	of	metagenomics,	metatranscriptomics	and
metaproteomics	data	of	two	different	adult	conditions:	10d	and	20d.
Comparison	of	metagenomics	and	metatranscriptomics/metaproteomics	data	sets	for	one-condition
sample	(Multi-meta-omic	approach)
Assessing	bacterial	composition	from	metagenomics	and	metatranscriptomics	data
The	analysis	of	microbial	community	samples	often	raises	the	question	of	which	bacteria	form	a	given
population.	To	answer	this	question,	we	performed	two	different	types	of	analysis	using	gNOMO.	First,
we	processed	and	analyzed	metagenomics	data	to	investigate	the	taxonomic	composition	of	a	given
sample.	Second,	we	analyzed	and	compared	samples	of	two	different	conditions:	10d	and	20d.
For	the	first	analysis,	the	output	was	visualized	using	a	Krona	plot	that	is	produced	for	each
metagenomics	and	metatranscriptomics	sample	automatically	within	the	gNOMO	pipeline.	For	the
first-condition	(10d)	sample,	we	observed	that	the	main	phyla	present	in	this	population	were
Bacteroidetes,	Firmicutes,	and	Proteobacteria	(Figure	2)..	After	analyzing	the	taxonomic	distribution
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differences	between	the	10d	and	20d	samples,	we	observed	no	significant	abundance	differences	in	a
preliminary	analysis	(Additional	file	1:	Tables	S3	and	S4)..	In	this	analysis,	the	relative	abundance	of
the	main	phyla	and	families	was	calculated	in	relation	to	the	mean	abundance	of	the	two	conditions.
We	observed	that	the	four	most	abundant	phyla	distributions	match	our	previous	published	studies
based	on	16S	gene	sequencing,	while	others	(e.g.,	Planctomycetes,	Deferribacteres	and
Actinobacteria)	do	not	match	exactly	previous	studies	on	this	topic	[10]	(Additional	file	1:	Table	S3)..
We	made	similar	observations	regarding	taxonomic	abundances	at	the	family	level	(Additional	file	1:
Table	S4)..	In	general,	this	can	be	explained	by	the	difference	concerning	the	method	and	annotation
between	16S	rRNA	gene	sequencing	analysis	and	metagenomics.	16S	rRNA	gene	sequencing	focuses
on	bacterial	data	and	can	be	useful	in	environmental	studies	due	to	the	lack	of	fully	sequenced
bacterial	genomes	in	these	kinds	of	scenarios.	In	contrast,	metagenomics	offers	higher	resolution,
enabling	a	more	specific	taxonomic	classification	of	sequences	as	well	as	the	detection	of	new
bacterial	genes	and	genomes	[43].	
Figure	2:	KronaPlot	of	the	taxonomic	annotation	of	a	metagenomics	sample	(condition	10d).		Bacterial
taxa	distribution	of	metagenomics	data,	corresponding	to	condition	10d.	The	bacterial	taxa	are
classified	by	taxonomic	hierarchy	levels,	from	higher	levels	in	the	center	of	the	chart	(Kingdom
Bacteria)	progressing	outward	until	genus	level.	
As	described	previously,	our	first	analysis	provided	no	clearly	visible	abundance	differences	between
the	two	conditions,	as	we	were	expecting	when	studying	such	a	stable	situation	(both	are	adult
individuals	differing	in	10	days	of	development).	However,	we	decided	to	validate	this	finding	by	a
more	sensitive	statistical	approach.	To	investigate	this	issue	further,	we	used	LEfSe	[39]	as	a	well-
established	statistical	method	for	comparing	the	taxonomic	distribution	at	genus	level	between	10d
and	20d	conditions.	LEfSe	has	the	advantage	of	recognizing	the	hierarchy	of	the	taxonomic
classification	and	accurately	calculate	statistically	significant	differences	(represented	as	LDA	scores)
between	different	conditions.	
Using	LEfSe,	we	found,	for	example,	that	Fusobacterium	(Fusobacteriaceae	family),	was	more
abundant	at	10	days	(LDA	score	>	3)	in	both	metagenomics	and	metatranscriptomics	data	(Figure	3)..
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Fusobacterium	has	been	related	to	disease	and	stress	situations	in	the	human	gut	microbiota	[44],
but	is	has	also	been	related	to	the	infants	gut	microbiota	[45].	Conversely,	an	unidentified	genus
belonging	to	the	family	Ruminococcaceae,	has	been	found	more	abundant	in	20d	than	10d	condition
(LDA	score	>	3)	in	metagenomics	data	(Figure	3a),,	but	no	differences	between	conditions	have	been
found	in	metatranscriptomics	data	(Figure	3b)..	Various	genera	belonging	to	the	family
Ruminococcaceae	have	been	related	to	a	healthy	gut	microbiota,	like	Ruminococcus	and
Faecalibacterium.	These	have	been	linked	to	degradation	of	starch	in	the	human	colon	making	it
available	for	other	bacteria	in	the	gut	[46],	and	degradation	of	cellulose	in	herbivorous	mammals	[47].
These	differences	between	10d	and	20d	conditions	could	suggest	that,	even	if	the	population	is	very
stable	along	adult	stages,	it	is	being	rearranged	to	its	final	composition.	This	rearrangement	would
imply	a	reduction	in	Fusobacterium	and	an	increase	of	Ruminococcaceae	along	time	(10d	against
20d,	Figure	3a)..	On	the	other	hand,	Pseudomonas	genus	and	an	unclassified	genus	belonging	to	the
family	Pelagibacteraceae	are	more	abundant	only	in	metatranscriptomics	analysis	at	20d	against
10d	(Figure	3b)..	Pelagibacteraceae	has	been	described	as	a	bacterial	family	localized	in	marine	and
freshwater	environments	[48],	but	has	also	been	detected	in	the	mouse	gut	microbiome	[49]
Pseudomonas	genus	has	been	related	to	pathogenicity	in	animals	and	plants,	and	is	a	commonly
detected	taxa	in	the	gut	of	cockroaches	[50].	These	results	suggest	that	these	taxa	increase	their
transcriptional	activity	but	not	their	abundance	in	the	population	along	time.	By	the	same	reason	the
unidentified	genus	of	Ruminococcaceae	reduce	its	transcriptional	activity	(is	overrepresented	at
metagenomics	level	but	not	at	metatranscriptomics	level	in	20d	sample).	More	importantly	for	the
present	work	is	the	integration	of	this	level	of	comparison	that	allows	detection	of	particular	taxa	that
differ	significantly	in	their	abundance	in	different	conditions.
Figure	3:	LEfSe	graph	of	taxonomic	annotation	of	metagenomics	(top)	and	metatranscriptomics
(bottom)	data	comparing	the	two	conditions:	10d	and	20d.	Taxa	with	significant	different	distribution
among	the	two	conditions	are	identified.	Only	taxa	with	LDA	scores	over	2	are	shown.	Positive	LDA
scores	are	assigned	to	the	taxa	overrepresented	in	the	condition	20d	(green),	and	negative	LDA
scores	to	the	taxa	overrepresented	in	the	condition	10d	(red).	metagenomics	data	(Fig	3a)	and
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metatranscriptomics	data	(Fig	3b)	are	represented.	
Functional	analysis	from	integrated	metagenomics	and	metatranscriptomics	data	for	one-condition
sample
Once	the	bacterial	population	has	been	described	at	the	taxonomic	level,	the	next	step	concerns	the
functional	analysis	of	each	microbiome	dataset	and	the	qualitative	and	quantitative	differences	of
assigned	functional	annotations.	To	assess	the	level	of	transcriptional	activity	of	the	population,	we
compare	the	metagenomics	data	(gene	pool)	and	the	metatranscriptomics	data	(transcripts)
corresponding	to	the	microbiota	of	the	10d	condition.	Integrating	metagenomics	and
metatranscriptomics	allows	calculating	transcript/gene	ratios	that	indicate	gene	transcriptional
activation	or	repression.	For	this	purpose,	we	applied	LEfSe	based	on	the	functional	role	(or	subrole)
assignment	using	TIGRFAM	(Figure	4;	Additional	file	1:	Table	S5)..	We	observed	that	energy
metabolism	(both	anaerobic	and	aerobic	metabolisms)	and	protein	production	are	the	most	active
metabolic	pathways	(Figure	4),,	which	indicates	that	the	bacterial	population	is	active.	
Figure	4:	LEfSe	graph	comparing	metagenomics	and	metatranscriptomics	data	of	TIGRFAM	annotation
(role	and	subrole	levels)	of	condition	10d.	Taxa	with	significant	different	distribution	among
metagenomics	and	metatranscriptomics	data	are	identified.	Only	taxa	with	LDA	scores	above	2	are
shown.	Positive	LDA	scores	are	assigned	to	the	functional	categories	overrepresented	in	the
metatranscriptomics	data	(RNA,	green),	and	negative	LDA	scores	to	the	functional	categories
overrepresented	in	metagenomics	data	(DNA,	red).
Alternatively,	a	pathway	analysis	enables	to	discover	differences	between	states	by	using	the
Pathview	R	package.	An	analysis	with	Pathview	shows	which	specific	metabolic	pathways	(KEGG
pathways)	have	statistically	significant	correlations	between	sample	types	and/or	conditions	and
thereby	complements	the	information	provided	by	LEfSe.	In	a	Pathview	graph,	an	increase	of	the
gene	activity	involved	in	a	certain	pathway	can	be	observed.	Our	exemplary	analysis	using	Pathview
here	focuses	on	the	tricarboxylic	acid	cycleTCA	cycle)	of	the	gut	microbiota,	comparing	again	gene
pool	(metagenomics	data)	against	transcripts	(metatranscriptomics	data)	(Figure	5)..	The	TCA	cycle
consists	of	a	series	of	oxidative	reactions	to	finally	obtain	energy	(ATP)	from	oxidative	degradation	of
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the	acetyl	group,	in	the	form	of	acetyl-CoA,	to	carbon	dioxide.	The	full	cycle	can	be	performed	by
bacteria	in	aerobic	conditions,	but	some	autotrophic	bacteria	are	also	able	to	perform	the	reverse	TCA
cycle	(rTCA),	and	even	some	anaerobic	bacteria	are	able	to	carry	out	an	incomplete	TCA	cycle,
defining	the	pan-metabolic	capabilities	for	this	pathway	of	the	gut	microbiota.
We	have	found	that	the	majority	of	the	enzymes	that	take	part	in	the	TCA	cycle	are	overrepresented
at	the	transcript	level.	This	confirms	our	previous	observations	related	to	energy	metabolism	(Figure
4)..	With	both	analysis	methods	and	their	visualizations,	we	were	able	to	study	different	levels	of
complexity	of	the	pan-metabolism	of	all	bacterial	populations.	We	observed	that	the	microbiome
actively	produces	energy	and	proteins	to	grow	and	maintain	a	very	complex	population.	Beyond	the
use	case	shown	above,	depending	on	the	particular	study,	other	pathways	could	be	analyzed.	
Figure	5:	KEGG	Pathview	graph	of	the	TCA	cycle	metabolism	route	comparing	metagenomics	vs.
metatranscriptomics	data	of	the	microbiota	of	10d	and	20d	conditions.	Some	nodes	are	split	between
two	colors,	indicating	10d	(left)	and	20d	(right)	conditions.	Green	(–1)	depicts	genes
underrepresented	in	metagenomics	(but	overrepresented	in	metatranscriptomics),	while	those
marked	in	red	(1)	depicts	overrepresented	genes	in	metagenomics	(but	underrepresented	in
metatranscriptomics).	In	grey,	values	close	to	0	in	the	ratio	metatranscriptomics/metagenomics,
indicating	no	differences	in	frequency.
Meta-omics	integration:	comparing	metagenomics,	metatranscriptomics,	and	metaproteomics	data	at
the	functional	pathway	level
Each	meta-omics	level	data	provides	unique	information	in	various	ways,	but	their	integration	is
crucial	to	gain	a	complete	overview	of	the	metabolic	capabilities	of	the	studied	bacterial	populations.
metaproteomics	data	incorporation	to	the	integrated	analysis	of	microbiomes	is	essential	to	have	a
realistic	overview	of	the	functional	capabilities	of	the	bacterial	populations.	For	this	purpose,	we
analysed	these	meta-omics	data	together,	as	an	example,	focussing	on	the	N	metabolism	pathway,
corresponding	to	the	N	cycle,	the	set	of	reactions	by	which	different	inorganic	N	compounds	are
transformed	into	ammonia,	a	biologically	reduced	form	of	N	that	can	be	mainly	introduced	into
synthesis	of	amino	acids	(glutamine	and	glutamate).	We	were	interested	in	this	pathway	due	to
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previous	findings	related	to	N	metabolism	of	the	host	(B.	germanica)	and	the	endosymbiont
Blattabacterium.	As	explained	previously,	Blattabacterium	participates	in	the	N	recycling	from	stored
urates	to	ammonia	that	can	be	used	to	synthesize	glutamine	and	glutamate,	connecting	with	the
amino	acid	biosynthesis	pathway	[6].	Here,	the	aim	was	to	study	N	metabolism	in	the	host	gut
microbiome	and	then	to	assess	if	the	bacterial	population	has	the	metabolic	capability	to	produce	a
form	of	usable	N.	
In	this	analysis,	we	investigated	how	variable	or	stable	the	overall	N	metabolism	is	at	the	gene,
transcript	and	protein	level	along	time	(10d	against	20d)	in	the	investigated	pathway	(Figure	6)..
While	metagenomics	and	metatranscriptomics	show	almost	complete	coverage	of	the	N	metabolism
pathways	and	very	variable	along	time,	only	a	few	enzymes	were	observed	in	the	metaproteomics
data	and	very	stable	along	time.	These	results	suggest	that	while	the	gene	pool	(the	population)	can
be	variable,	the	final	transcripts	and	at	least	the	four	detected	proteins	remain	stable,	which	could
point	in	the	direction	of	a	functional	redundancy	at	the	protein	level,	as	has	been	previously	described
for	human	gut	microbiota	[51].	However,	deeper	coverage	of	the	metaproteomics	data	would	be
necessary	to	confirm	these	findings.	
Figure	6:	KEGG	Pathview	graph	of	the	N	metabolism	route	comparing
metagenomics/metatranscriptomics/metaproteomics	data	of	the	microbiome	at	10d	and	20d.	Some
nodes	are	split	between	different	colors,	indicating	metagenomics	(left),	metatranscriptomics	(middle)
and	metaproteomics	(right)	data.	Green	(–1)	depicts	genes/transcripts/proteins	overrepresented	in
10d	(but	underrepresented	in	20d),	while	those	marked	in	red	(1)	depicts	genes/transcripts/proteins
overrepresented	in	20d	(but	underrepresented	in	10d).	In	grey,	values	close	to	0	in	the	ratio	10d/20d,
indicating	no	differences	in	frequency.
Comparison	of	host	and	microbiome	data	
Microbiota	metabolism	and	functions	are	better	understood	when	studied	together	with	its	host.
gNOMO	includes	the	analysis	of	the	host	data	in	parallel	with	its	microbiome,	so	we	can	integrate	and
compare	the	metabolic	pathways	of	host	and	microbiome.	In	the	case	of	B.	germanica,	we	have
studied	the	N	metabolism	pathway	that	we	had	analyzed	before	with	the	focus	on	the	microbiota	data
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(Figure	6)	integrating	the	host	data	(Figure	7)..	We	have	observed	which	enzymes	can	be	found	in	the
bacterial	population	data	and	which	ones	can	be	explained	by	the	host	data	(Figure	6	and	7)..	
We	expected	to	find	a	maximum	of	four	enzymes	in	the	host	data,	as	in	most	eukaryotes	only	four
enzymes	of	this	pathway	are	present,	and	we	could	detect	those	in	the	host	pathway.	While	these
four	enzymes	were	the	only	ones	detected	in	the	host,	its	gut	microbiome	possesses	most	of	the
enzymes	present	in	the	N	metabolism	pathway.	
If	we	study	these	four	enzymes	present	in	the	host	data	in	detail,	we	can	observe	that	all	of	them	are
overrepresented	at	10d	against	20d	condition	in	metaproteomics	data,		and	in	metagenomics	and
metatranscriptomics	data,	they	are	almost	undetectable	(Figure	7)..	When	looking	at	the	microbiome
metatranscriptomics	data,	these	proteins	have	a	stable	abundance	over	the	whole	time	(Figure	6)..
These	findings	could	indicate	that	the	production	of	these	proteins	in	the	hindgut	of	the	host	is
reduced	along	time,	but	its	production	by	the	microbiome	remains	stable.	
After	analyzing	the	bacterial	and	the	host	capabilities	together	regarding	this	metabolic	pathway,	we
find	that	the	N	metabolism	corresponding	to	the	N	cycle	is	mostly	performed	by	the	microbiome.	
Figure	7:	KEGG	Pathview	graph	of	the	N	metabolism	pathways	comparing
metagenomics/metatranscriptomics/metaproteomics	data	of	the	host	between	10d	and	20d
conditions.	Some	nodes	are	split	between	different	colors,	indicating	metagenomics	(left),
metatranscriptomics	(middle)	and	metaproteomics	(right)	data.	Green	(–1)	depicts
genes/transcripts/proteins	overrepresented	in	10d	(but	underrepresented	in	20d),	while	those	marked
in	red	(1)	depicts	genes/transcripts/proteins	overrepresented	in	20d	(but	underrepresented	in	10d).	In
grey,	values	close	to	0	in	the	ratio	10d/20d,	indicating	no	differences	in	frequency.
Discussion
The	aim	of	our	software	design	and	implementation	was	to	provide	a	complete	pipeline	to	analyze
omics	data	from	a	non-model	host	and	its	microbiome.	Based	on	these	requirements,	we	developed
the	gNOMO	software	that	presents	an	end-to-end	workflow	covering	all	the	required	data	analysis
steps	starting	from	the	processing	of	raw	omics	data	to	the	final	output	visualization	of	the	results.
gNOMO	performs	the	analysis	of	up	to	three	different	meta-omics	data:	metagenomics,
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metatranscriptomics	and	metaproteomics,	and	their	integration.
gNOMO	is	designed	for	paired-end	sequencing	of	metagenomics	and	metatranscriptomics	data,	the
pipeline	includes	a	preprocessing	and	binning	step	designed	for	this	type	of	datasets.	A	tailored
proteogenomic	database	is	generated	to	perform	a	highly	efficient	database	search	for	protein
identification	in	the	metaproteomics	data	analysis	without	a	reference	microbiome.	To	obtain	this
database	metagenomics	and	metatranscriptomics	data	are	assembled	into	contigs,	which	are	then
used	to	predict	the	proteins	present	in	the	samples.	Together	with	the	microbiome	data,	host	data	is
obtained	from	the	same	samples	and	analyzed	de	novo	in	order	to	be	able	to	analyze	microbiota	of
non-model	organisms	integrated	with	the	host	information.	Host	databases	can	also	be	provided	to
analyze	human	or	other	model	organisms	data.	
The	pipeline	is	developed	using	the	modular	Snakemake	framework	that	allows	to	incorporate
software	tools	and	libraries	with	different	requirements.	These	tools	are	available	at	the	BioConda
channel	and	their	installation	is	incorporated	in	the	workflow.	Snakemake	makes	use	of	programming
languages	Python	and	Bash,	which	are	commonly	used	in	bioinformatics.	Parameters	can	be	specified
in	the	configuration	file	provided	to	Snakemake,	so	it	can	be	adapted	to	any	kind	of	host	or
microbiome	analyzed.	The	use	of	Snakemake	makes	gNOMO	fully	automated,	efficient,	and
reproducible.	
Previously	published	meta-omics	workflows	such	as	Imetaproteomics	[17]	incorporate	two	layers	of
meta-omics	information	by	integrating	metagenomics	and	metatranscriptomics	data.	Such	workflows
focus	on	the	analysis	of	the	microbiome	and	often	consider	host	information	as	contaminant	reads:
thus,	instead	of	providing	a	host	data	analysis,	the	host	genome	is	only	used	to	remove	the	host
information	from	the	microbiome	data.	To	overcome	this	issue,	gNOMO	offers	the	possibility	to
analyze	host	data	in	parallel	to	microbiome	data	and	both	datasets	can	be	studied	simultaneously.
gNOMO	includes	the	analysis	of	metaproteomics	data	and	creates	a	tailored	proteogenomic	database
to	achieve	better	and	more	efficient	protein	identification.	The	incorporation	of	the	metaproteomics
data	to	the	study	of	the	microbiome	gives	another	dimension	to	the	analysis	of	the	microbiome
because	the	proteome	provides	the	functional	profile	and	thereby	gives	insights	on	the	actual
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interaction	between	microbial	populations	and	their	host.
The	visualization	output	provided	by	gNOMO	pipeline	includes	krona	charts	for	taxonomic	distribution,
and	KO	categories	are	plotted	using	Pathview	graphs.	The	functional	distribution	represented	with
Pathview	permits	to	investigate	two	different	aspects:	first,	the	completeness	of	the	metabolic
pathways	by	visualizing	each	enzyme	in	the	route,	and	second,	the	differences	in	abundance	of	each
enzyme	by	comparing	datasets	(metagenomics,	metatranscriptomics	and	metaproteomics)	or
conditions.	This	integration	in	gNOMO	is	highly	useful,	for	example,	when	information	regarding	the
presence	and	abundance	of	specific	enzymes	is	needed.	
Conclusions
gNOMO	is	a	standardized	and	reproducible	bioinformatic	pipeline	designed	to	integrate	and	analyze
metagenomics,	metatranscriptomics,	and	metaproteomics	microbiota	data	of	non-model	organisms.	It
incorporates	preprocessing,	binning,	assembly	steps,	taxonomic	and	functional	annotations,	and	the
production	of	a	proteogenomic	database	to	improve	the	metaproteomics	analysis.	gNOMO	also
includes	the	analysis	of	both	microbiota	and	host	data	in	parallel,	which	makes	it	a	useful	tool	to
analyze	the	microbiome	of	non-model	organisms,	as	it	was	demonstrated	using	experimental	data	of
the	German	cockroach	B.	germanica.	In	general,	gNOMO	can	also	be	applied	to	data	from	human	or
other	model	organism	sample	types.	Finally,	gNOMO	generates	output	and	visualization	of	multiple
meta-omics	results	in	a	single	automated	pipeline.	
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Figure	1
Workflow	overview	of	the	gNOMO	pipeline.	A)	Initial	input	of	metagenomic	(metagenomics)
and	metatranscriptomic	(metatranscriptomics)	sequences.	B)	Pre-processing:	cleaning	and
quality	control	of	metagenomics	and	metatranscriptomics	input	sequences.	C)
metagenomics	and	metatranscriptomics	data	analyses:	consists	of	taxonomic	and	functional
annotations.	D)	Proteogenomic	database	creation	based	on	metagenomics	and
metatranscriptomics	protein	predictions.	E)	Auxiliary	input	of	metaproteomic
(metaproteomics)	tandem	mass	spectrum	data.	F)	metaproteomics	analysis:	also	includes
taxonomic	and	functional	annotations.	G)	Graphical	representation/visualization	of	all
integrated	meta-omics	data.
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Figure	2
KronaPlot	of	the	taxonomic	annotation	of	a	metagenomics	sample	(condition	10d).	Bacterial
taxa	distribution	of	metagenomics	data,	corresponding	to	condition	10d.	The	bacterial	taxa
are	classified	by	taxonomic	hierarchy	levels,	from	higher	levels	in	the	center	of	the	chart
(Kingdom	Bacteria)	progressing	outward	until	genus	level.
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Figure	3
LEfSe	graph	of	taxonomic	annotation	of	metagenomics	(top)	and	metatranscriptomics
(bottom)	data	comparing	the	two	conditions:	10d	and	20d.	Taxa	with	significant	different
distribution	among	the	two	conditions	are	identified.	Only	taxa	with	LDA	scores	over	2	are
shown.	Positive	LDA	scores	are	assigned	to	the	taxa	overrepresented	in	the	condition	20d
(green),	and	negative	LDA	scores	to	the	taxa	overrepresented	in	the	condition	10d	(red).
metagenomics	data	(Fig	3a)	and	metatranscriptomics	data	(Fig	3b)	are	represented.
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Figure	4
LEfSe	graph	comparing	metagenomics	and	metatranscriptomics	data	of	TIGRFAM
annotation	(role	and	subrole	levels)	of	condition	10d.	Taxa	with	significant	different
distribution	among	metagenomics	and	metatranscriptomics	data	are	identified.	Only	taxa
with	LDA	scores	above	2	are	shown.	Positive	LDA	scores	are	assigned	to	the	functional
categories	overrepresented	in	the	metatranscriptomics	data	(RNA,	green),	and	negative	LDA
scores	to	the	functional	categories	overrepresented	in	metagenomics	data	(DNA,	red).
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Figure	5
KEGG	Pathview	graph	of	the	TCA	cycle	metabolism	route	comparing	metagenomics	vs.
metatranscriptomics	data	of	the	microbiota	of	10d	and	20d	conditions.	Some	nodes	are	split
between	two	colors,	indicating	10d	(left)	and	20d	(right)	conditions.	Green	(-1)	depicts
genes	underrepresented	in	metagenomics	(but	overrepresented	in	metatranscriptomics),
while	those	marked	in	red	(1)	depicts	overrepresented	genes	in	metagenomics	(but
underrepresented	in	metatranscriptomics).	In	grey,	values	close	to	0	in	the	ratio
metatranscriptomics/metagenomics,	indicating	no	differences	in	frequency.
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Figure	6
KEGG	Pathview	graph	of	the	N	metabolism	route	comparing
metagenomics/metatranscriptomics/metaproteomics	data	of	the	microbiome	at	10d	and
20d.	Some	nodes	are	split	between	different	colors,	indicating	metagenomics	(left),
metatranscriptomics	(middle)	and	metaproteomics	(right)	data.	Green	(-1)	depicts
genes/transcripts/proteins	overrepresented	in	10d	(but	underrepresented	in	20d),	while
those	marked	in	red	(1)	depicts	genes/transcripts/proteins	overrepresented	in	20d	(but
underrepresented	in	10d).	In	grey,	values	close	to	0	in	the	ratio	10d/20d,	indicating	no
differences	in	frequency.
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Figure	7
KEGG	Pathview	graph	of	the	N	metabolism	pathways	comparing
metagenomics/metatranscriptomics/metaproteomics	data	of	the	host	between	10d	and	20d
conditions.	Some	nodes	are	split	between	different	colors,	indicating	metagenomics	(left),
metatranscriptomics	(middle)	and	metaproteomics	(right)	data.	Green	(-1)	depicts
genes/transcripts/proteins	overrepresented	in	10d	(but	underrepresented	in	20d),	while
those	marked	in	red	(1)	depicts	genes/transcripts/proteins	overrepresented	in	20d	(but
underrepresented	in	10d).	In	grey,	values	close	to	0	in	the	ratio	10d/20d,	indicating	no
differences	in	frequency.
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